• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Entero Healthcare Solutions Ltd.
    20 Mar 2025
    1183.20
    -1.05%
    Entero Healthcare launches digital solution HealthEdge for retail chemists
    Business Line
    Entero acquires Aayu Chemist app and Medcords platform
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 86 to 80 in Jun 2025 qtr
    logo
    Kovai Medical Center and Hospital Ltd.
    18 Mar 2025
    6320.25
    0.15%
    Coimbatore's Kovai Medical Center and Hospital eyes Chennai expansion
    Business Line
    The Board of KMCH has approved a proposal for the purchase of around 1.11 acres of land and building located in Sholingannalur
    Copy LinkShare onShare on Share on Share on
    Kovai Medical Center and Hospital Ltd. has gained 25.74% in the last 6 Months
    logo
    Inventurus Knowledge Solutions Ltd.
    18 Mar 2025
    1535.10
    -0.07%
    Inventurus Knowledge Solutions Gets 'Hold' On Jefferies Initiation
    Inventurus Knowledge Solutions Gets 'Hold' On Jefferies Initiation
    NDTV Profit
    With pricey valuations at a 50-90% premium to peers, the upside to IKS stock is limited, Jefferies said in a note.
    Copy LinkShare onShare on Share on Share on
    Inventurus Knowledge.. has an average target of 1820.00 from 4 brokers.
    logo
    Dr. Lal Pathlabs Ltd.
    17 Mar 2025
    Insider Trades
    3283.90
    1.87%
    'Add' Dr. Lal Pathlabs Maintains HDFC Securities But Lowers Target Price  Here's Why
    'Add' Dr. Lal Pathlabs Maintains HDFC Securities But Lowers Target Price Here's Why
    NDTV Profit
    The diagnostic sector experienced de-rating in the last few quarters due to moderate earnings growth, and Dr. Lal is trading at 42x/37x PE; this is at an 15/24% discount to its long-term mean of 49x.
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd.'s price crossed above 30Day SMA today
    logo
    Inventurus Knowledge Solutions Ltd.
    10 Mar 2025, 01:23PM
    1535.10
    -0.07%
    Here's Why Inventurus Knowledge Solutions Gets A 'Hold' Rating As ICICI Securities Initiates Coverage
    Here's Why Inventurus Knowledge Solutions Gets A 'Hold' Rating As ICICI Securities Initiates Coverage
    NDTV Profit
    While the brokerage likes Inventurus' business for its superior financial performance, technology prowess and attractive large scale opportunity; valuations at 33x FY27E P/E are rich, recommends Hold
    Copy LinkShare onShare on Share on Share on
    Inventurus Knowledge Solutions Ltd.'s price crossed below 30Day SMA today
    logo
    Metropolis Healthcare Ltd.
    09 Mar 2025
    2124.80
    -1.34%
    Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition
    Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition
    NDTV Profit
    Agra's leading diagnostic chain Scientific Pathology is the second acquisition by Metropolis Healthcare in north India in the last three months.
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcar.. has an average target of 2114.50 from 4 brokers.
    logo
    Thyrocare Technologies Ltd.
    07 Mar 2025
    1254.60
    -3.00%
    'Parents who fail to....': Thyrocare's Dr A. Velumani says on cooking, leaves netizens impressed
    'Parents who fail to....': Thyrocare's Dr A. Velumani says on cooking, leaves netizens impressed
    Business Today
    He noted that this holds especially true for families with an annual income of 5-25 lakhs.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 80 to 99 in Jun 2025 qtr.
    logo
    Metropolis Healthcare Ltd.
    05 Mar 2025
    2124.80
    -1.34%
    'The real competition isn't bigger players...': Metropolis Healthcare's Ameera Shah on the unorganised market
    'The real competition isn't bigger players...': Metropolis Healthcare's Ameera Shah on the unorganised market
    Business Today
    Ameera Shah, Managing Director of Metropolis Healthcare, speaks about the company's growth plans, the competitive landscape, pricing strategies, and the role of technology in diagnostics.
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcare Ltd. has gained 27.72% in the last 6 Months
    logo
    Metropolis Healthcare Ltd.
    04 Mar 2025
    2124.80
    -1.34%
    Metropolis up 3% on plans to foray into Western UP with Scientific deal
    Business Standard
    Metropolis Healthcare plans to acquire Western UP-based Scientific Pathology on a slump sale basis
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcare Ltd. has gained 27.72% in the last 6 Months
    Metropolis Healthcare acquires Scientific Pathology to expand in western UP
    Business Today | 03 Mar 2025 1 more
    Metropolis Healthcare to acquire Agra's diagnostic chain, Scientific Pathology
    Business Line | 03 Mar 2025
    logo
    Chandan Healthcare Ltd.
    17 Feb 2025
    223.10
    -1.93%
    Chandan Healthcare shares list with 3.84% premium at  165.10 on the NSE SME
    Chandan Healthcare shares list with 3.84% premium at 165.10 on the NSE SME
    livemint
    Chandan Healthcare share price lists with 3.84% premium at 165.10 on the NSE SME on Friday. The Chandan Healthcare IPO had received strong response being subscribed more than 7 times. However Grey Market premium indicated listing with marginal premium
    Copy LinkShare onShare on Share on Share on
    Chandan Healthcare Ltd. is trading below its 30 day SMA of 236.8
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd